Lumida
/LNTH
⌘K
Lantheus Holdings Inc

Lantheus Holdings Inc

LNTH
$100.70USD-0.11%-0.12 today

MARKET CAP

6.6B

P/E (TTM)

24.3x

FWD P/E

DAY RANGE

$100 – $101

52W RANGE

$50
$112

AI Summary

Stalk
Buy NowMedium

LNTH established a Bullish Pivot Point in late June, signaling structural repair and a shift toward upward mean-reversion. The medium-term posture remains bullish within a Stage 2 uptrend, confirmed by higher highs and lows and sustained acceptance above the rising 9/20/50 EMAs. Currently, price is pulling back into the EMA support confluence amid oversold conditions without exhaustion, presenting a favorable Buy Now opportunity on pullback and acceptance. A sustained close below the rising 50 SMA and short-term EMAs would invalidate this bullish stance.

  • Truist and B. Riley raised price targets from $115/97 to $125/129
  • Established nuclear medicine oncology diagnostics franchise drives customer loyalty
  • Profitability metrics remain weak, raising sustainability concerns
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$425.2M$935.1M$1.3B$1.5B$1.5B
YoY %+25.3%+119.9%+38.6%+18.3%+0.5%
P / Sales4.6x3.8x3.4x4.2x3.0x
EV / Sales5.3x4.3x3.5x4.2x3.5x
Gross Profit, Adj.$187.7M$581.7M$709.5M$988.3M$942.0M
YoY %+35.3%+209.9%+22.0%+39.3%-4.7%
Margin %44.1%62.2%54.7%64.4%61.1%
EV / Gross Profit12.0x6.9x6.4x6.5x5.7x
EBITDA, Adj.$-33.8M$84.1M$424.7M$513.2M$380.9M
YoY %-265.0%+348.9%+404.8%+20.8%-25.8%
Margin %-7.9%9.0%32.8%33.5%24.7%
EV / EBITDA-66.6x48.0x10.7x12.5x14.0x
EBIT$-76.1M$36.2M$364.6M$448.6M$310.8M
YoY %-1712.5%+147.6%+907.4%+23.0%-30.7%
Margin %-17.9%3.9%28.1%29.2%20.2%
EV / EBIT-29.6x111.6x12.5x14.2x17.2x
Net Income$-71.3M$28.1M$326.7M$312.4M$233.6M
YoY %-429.1%+139.4%+1063.9%-4.4%-25.2%
Net Margin-16.8%3.0%25.2%20.4%15.2%
EPS (GAAP)-$1.06$0.40$4.65$4.36$3.41
YoY %-324.0%+137.7%+1062.5%-6.2%-21.8%